Neoadjuvant immunochemotherapy versus chemotherapy for elderly patients with IB-IIIB non-small-cell lung cancer in real-world practice. Shuai Y, Liu J, Yang Y, Huang X, et al. BMC Cancer 2025;25:1150.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Shuai Y, Liu J, Yang Y, Huang X, et al. Neoadjuvant immunochemotherapy versus chemotherapy for elderly patients with IB-IIIB non-small-cell lung cancer in real-world practice. BMC Cancer 2025;25:1150.
PMID: 40619353